Ortho Phthalaldehyde Market Global Report 2026

The ortho phthalaldehyde market size has grown strongly in recent years. It will grow from $4.18 billion in 2025 to $4.42 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing hospital-acquired infection concerns, expansion of healthcare infrastructure, growth in surgical and diagnostic procedures, rising demand for high-level disinfectants in medical settings, adoption of chemical sterilization in laboratory environments.

The ortho phthalaldehyde market size is expected to see strong growth in the next few years. It will grow to $5.6 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing regulatory standards for infection control, rising demand for minimally toxic disinfectants, growth in outpatient surgical procedures, expansion of biotechnology and diagnostic laboratories, increasing focus on advanced hospital hygiene systems. Major trends in the forecast period include rising demand for high-level disinfectants in endoscope reprocessing workflows, increasing adoption of rapid-acting sterilants for hospital infection control, expansion of automated disinfection systems in diagnostic laboratories, shift toward low-residue chemical disinfectants for medical device safety, growing preference for stable high-efficacy aldehyde-based sterilization solutions.

The rising prevalence of hospital-acquired infections is anticipated to drive the growth of the ortho phthalaldehyde market going forward. Hospital-acquired infections (HAIs) refer to infections that patients contract during the course of receiving medical care in a healthcare facility, which are neither present nor incubating at the time of admission. The increasing incidence of hospital-acquired infections is attributed to the excessive use of invasive medical devices, which create direct entry routes for pathogens to penetrate the body and establish infections. Ortho-phthalaldehyde, functioning as a high-level disinfectant, aids in minimizing hospital-acquired infections by efficiently destroying a wide range of pathogens on medical instruments and surfaces used in clinical environments. For instance, in May 2024, according to the Center for Infectious Disease Research and Policy (CIDRAP), a US-based disease research organization, the number of patients acquiring at least one healthcare-acquired infection in hospitals across the European Union and European Economic Area was nearly 4.3 million per year in 2022 and 2023. Therefore, the rising prevalence of hospital-acquired infections is driving the growth of the ortho phthalaldehyde market.

The increasing number of surgical procedures is anticipated to propel the growth of the ortho phthalaldehyde market going forward. Surgical procedures are medical interventions that utilize manual or instrumental techniques to diagnose, treat, or manage diseases, injuries, or deformities by cutting, removing, repairing, or replacing body tissues. The rise in surgical procedures is driven by the growing prevalence of chronic diseases, which frequently advance to severe stages requiring surgical intervention for effective treatment and improved patient outcomes. Ortho-phthalaldehyde (OPA) supports surgical procedures by enabling high-level disinfection of critical medical instruments such as endoscopes and surgical tools, ensuring they remain free from harmful microorganisms. For instance, in February 2025, according to the 2024 annual report by Intuitive Surgical Inc., a US-based medical device company, approximately 2,683,000 surgical procedures were performed using da Vinci surgical systems, rising from around 2,286,000 procedures in 2023 and 1,875,000 procedures in 2022, reflecting consistent year-over-year growth in utilization. Therefore, the increasing number of surgical procedures is driving the growth of the ortho phthalaldehyde market.

The expanding geriatric population is expected to propel the growth of the ortho phthalaldehyde market going forward. The geriatric population refers to individuals aged 65 years and older who are more vulnerable to chronic health conditions due to age-related physiological changes. The growth in the geriatric population is driven by increasing life expectancy and declining birth rates, resulting in a larger proportion of older individuals within the total population. Ortho phthalaldehyde supports the geriatric population by facilitating rapid and effective high-level disinfection of medical instruments, thereby lowering the risk of healthcare-associated infections in elderly patients with weakened immune systems. For instance, in February 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, the global population of people aged 60 years and above is increasing rapidly due to longer life expectancy and declining birth rates, with older adults expected to surpass younger age groups in many regions by 2030. Therefore, the growing geriatric population is driving the growth of the ortho phthalaldehyde market.

Major companies operating in the ortho phthalaldehyde market are Thermo Fisher Scientific Inc., Merck KGaA, MP Biomedicals LLC, Simson Pharma Limited, Shodhana Laboratories Pvt. Ltd., Spectrum Chemical Manufacturing Corp., Otto Chemie Pvt. Ltd., Garonit Pharmaceutical, TCI Chemicals (India) Pvt. Ltd., Unilab Chemicals & Pharmaceuticals Pvt. Ltd., Loba Chemie Pvt. Ltd., Muby Chemicals, Freesia Chemicals, Microwin Labs Private Limited, Benzo Chem Industries Pvt. Ltd., N S Chemicals and Consultants Pvt. Ltd., Super Hygienic Chemicals, Affinity Specialty Chemicals, Ebele Cosmeceuticals, RYZE Chemie.

North America was the largest region in the ortho phthalaldehyde market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ortho phthalaldehyde market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ortho phthalaldehyde market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ortho phthalaldehyde market consists of sales of high-level disinfectant solutions for medical instruments, hospital-grade surface disinfection products, and laboratory and diagnostic equipment cleaning agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.